A Chicago woman was awarded $14 million in a medical malpractice case against her doctor after she suffered a severe stroke two weeks after starting the birth control Yasmin.
Mariola Zapalski, 37, was prescribed the controversial contraceptive pill by Dr. Zbigniew Aniol in 2007 to control irregular bleeding. 13 days later, she had a stroke which caused profound brain damage, causing her to become partially paralyzed and wheelchair bound. Zapalski now requires around-the-clock care by her husband, who is now unable to work.
A four woman, eight man jury reached the verdict on April 18 after a two-week trial before Cook County Circuit Judge Edward Washington II. The jury determined that the defendant, Dr. Aniol’s choice to prescribe the medication to Zapalski ultimately led to her life-long debilitating injury. Zapalski’s attorney Bradley Cosgrove said he hopes the “verdict will send a message to other health care providers to be very careful in prescribing this medication that can be very dangerous.”
ABOUT YASMIN
Yasmin, which is manufactured by Bayer HealthCare Pharmaceuticals, Inc., has been widely criticized for years by medical professionals because of its severe adverse side effects which among those side effects include a high risk of stroke in young women. Despite the controversy and known risks, Yasmin and YAZ continue to thrive in the pharmaceutical marketplace. In fact, in 2011 Bayer’s contraceptive medications generated $1.1 billion collectively making them the drug maker’s biggest selling drugs-Yasmin ranked as the No. 4 oral contraceptive in the United States.
In April 2012, the U.S. Food and Drug Administration ordered Bayer and other contraceptive makers to strengthen blood-clot warnings on their products. The FDA issued a safety review update last year for Yasmin and other birth control drugs containing drospirenone, a synthetic form of the naturally occurring female hormone progesterone. Medications with drospirenone have been found to triple the risk of blood clots.
As of March 2012, nearly 12,000 lawsuits have been brought against Bayer alleging that numerous contraceptive drugs, including Yasmin, enhance the risk of blood clots (deep vein thrombosis (DVT), pulmonary embolism (PE)) and gallbladder problems. Ocella, which is the generic version of Yasmin, is also associated with serious side effects, some of which have been found to be fatal. Lawsuits also allege that the company failed to adequately warn patients and medical professionals of increased risk of serious side effects associated with the use of Yasmin and Yaz as compared to safer oral contraceptives.
All of the oral contraceptives containing ethinyl estradiol and the new “fourth generation” progestin drospirenone (DRSP) have been linked to:
• Blood Clots • Deep Vein Thrombosis (DVT)
• Pulmonary Embolism • Gallbladder Disease • Stroke • Cerebrovascular Accidents (CVA)
• Heart Attack • Myocardial Infarction • Death Continue reading